Bright Health Group
direct contracting positions us to serve beneficiaries at scale brings fully aligned care the fee for service population market opportunity billion billion targeted approach centered around tightly aligned provider partners aligns strategy with long term vision around accountability for quality and total cost of care benefit enhancements enable more responsive care enables address the of spend in fee for service potential age ins from and improve advantage penetration | Bright Health Group
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
32 of 59
Similar slides by Bright Health Group
See diffirences between slides (animation)
Investor Presentation
January 2022
direct contracting positions us to serve beneficiaries at scale brings fully aligned care the fee for service population market opportunity billion fee for service aligns strategy with long term vision around accountability for quality and total cost of care benefit enhancements enable more responsive care potential age ins from and improve advantage penetration enables address the of spend in fee for service around tightly aligned acne | Bright Health Group
Related slides by other companies
Nuvalent
Investor Presentation
January 2024
potential best in class profile for opportunity to both move up the treatment paradigm grow the market with deep durable responses no clear standard of care soc mutation disease current soc of disease demonstrated activity where current available therapies have failed opportunity to supplant standard of care with a differentiated clinical activity observed in heavily patients with who likely exhausted all available therapies including after or with resistance mutations with history of metastasis including intracranial responses to address combined medical needs mutation coverage activity avoiding off target adverse events opportunity to drive deep durable responses favorable preliminary safety consistent with selective sparing design sources sales and forecasts accessed lin precision and lung cancer a | Nuvalent
Equillium
Investor Presentation
August 2023
opportunity celiac disease has no approved therapies celiac disease billion dollar annual market opportunity me | Equillium
Quanergy
SPAC
June 2021
opportunity for in the automotive market | Quanergy
Quanergy
SPAC
June 2021
opportunity for and perception in markets lot | Quanergy
Other recent decks by Bright Health Group
See all presentations (3 decks)
Results
May 2022
Investor Presentation
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io